Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morie Gertz

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.
Blood|July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's MacroglobulinemiaVéronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.
American Journal of Hematology|July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal proteinMarcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.
American Journal of Hematology|February 19, 2019
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosisM Hasib Sidiqi, Surendra Dasari, Ellen D McPhail, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Leukemia|June 17, 2024
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessmentJean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Leukemia|December 9, 2022
Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessmentJean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Bone Marrow Transplantation|June 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020Ben Lerman, Stefan Schönland, Ute Hegenbart, et al.
Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
Blood|February 5, 2011
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3Meletios Dimopoulos, Robert Kyle, Jean-Paul Fermand, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.
Blood|July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's MacroglobulinemiaVéronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.
American Journal of Hematology|July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal proteinMarcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.
American Journal of Hematology|February 19, 2019
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosisM Hasib Sidiqi, Surendra Dasari, Ellen D McPhail, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Leukemia|June 17, 2024
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessmentJean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Leukemia|December 9, 2022
Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessmentJean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Bone Marrow Transplantation|June 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020Ben Lerman, Stefan Schönland, Ute Hegenbart, et al.
Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
Blood|February 5, 2011
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3Meletios Dimopoulos, Robert Kyle, Jean-Paul Fermand, et al.
Pageof 12